324 related articles for article (PubMed ID: 34102254)
1. Relaxin in hepatic fibrosis: What is known and where to head?
Ezhilarasan D
Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
[TBL] [Abstract][Full Text] [Related]
2. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.
Kaftanovskaya EM; Ng HH; Soula M; Rivas B; Myhr C; Ho BA; Cervantes BA; Shupe TD; Devarasetty M; Hu X; Xu X; Patnaik S; Wilson KJ; Barnaeva E; Ferrer M; Southall NT; Marugan JJ; Bishop CE; Agoulnik IU; Agoulnik AI
FASEB J; 2019 Nov; 33(11):12435-12446. PubMed ID: 31419161
[TBL] [Abstract][Full Text] [Related]
4. A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats.
Kim JK; Lee JI; Paik YH; Yun CO; Chang HY; Lee SY; Lee KS
J Gene Med; 2016; 18(1-3):16-26. PubMed ID: 26769058
[TBL] [Abstract][Full Text] [Related]
5. Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives.
Sassoli C; Nistri S; Chellini F; Bani D
Curr Mol Med; 2022; 22(3):196-208. PubMed ID: 33687895
[TBL] [Abstract][Full Text] [Related]
6. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue.
Bennett RG; Mahan KJ; Gentry-Nielsen MJ; Tuma DJ
Ann N Y Acad Sci; 2005 May; 1041():185-9. PubMed ID: 15956705
[TBL] [Abstract][Full Text] [Related]
7. Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.
Fallowfield JA; Hayden AL; Snowdon VK; Aucott RL; Stutchfield BM; Mole DJ; Pellicoro A; Gordon-Walker TT; Henke A; Schrader J; Trivedi PJ; Princivalle M; Forbes SJ; Collins JE; Iredale JP
Hepatology; 2014 Apr; 59(4):1492-504. PubMed ID: 23873655
[TBL] [Abstract][Full Text] [Related]
8. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
Mardhian DF; Storm G; Bansal R; Prakash J
J Control Release; 2018 Nov; 290():1-10. PubMed ID: 30287265
[TBL] [Abstract][Full Text] [Related]
9. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
10. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
11. Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.
Iredale JP; Pellicoro A; Fallowfield JA
Dig Dis; 2017; 35(4):310-313. PubMed ID: 28467988
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
13. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling.
Li J; Wang Y; Ma M; Jiang S; Zhang X; Zhang Y; Yang X; Xu C; Tian G; Li Q; Wang Y; Zhu L; Nie H; Feng M; Xia Q; Gu J; Xu Q; Zhang Z
EBioMedicine; 2019 Feb; 40():43-55. PubMed ID: 30639416
[TBL] [Abstract][Full Text] [Related]
14. Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
Caon E; Martins M; Hodgetts H; Blanken L; Vilia MG; Levi A; Thanapirom K; Al-Akkad W; Abu-Hanna J; Baselli G; Hall AR; Luong TV; Taanman JW; Vacca M; Valenti L; Romeo S; Mazza G; Pinzani M; Rombouts K
J Hepatol; 2024 Jun; 80(6):941-956. PubMed ID: 38365182
[TBL] [Abstract][Full Text] [Related]
15. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.
Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S
Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327
[TBL] [Abstract][Full Text] [Related]
16. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.
Bennett RG; Simpson RL; Hamel FG
World J Gastroenterol; 2017 Jun; 23(22):3999-4006. PubMed ID: 28652653
[TBL] [Abstract][Full Text] [Related]
17. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
18. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
19.
Hsu WH; Liao SC; Chyan YJ; Huang KW; Hsu SL; Chen YC; Siu ML; Chang CC; Chung YS; Huang CF
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137784
[TBL] [Abstract][Full Text] [Related]
20. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
